自噬在肝癌介入治疗中的研究进展

摘要/Abstract

摘要： 原发性肝癌是我国最常见的恶性肿瘤之一,介入治疗覆盖中国肝癌分期Ⅰa~Ⅲb期的患者。自噬作为真核细胞特有的代谢过程,参与代谢性疾病、恶性肿瘤的发生、发展,在肝癌的发生、发展中发挥重要作用,尤其促进了肿瘤细胞对介入治疗的耐受,使得治疗效果不佳。本文综述了原发性肝癌常见介入治疗方式对肿瘤细胞自噬现象的影响：消融治疗、经血管介入治疗及内放射治疗都会通过缺氧诱导因子1α（hypoxia inducible factor-1α,HIF-1α）/B淋巴细胞瘤2/腺病毒E1B相互作用蛋白3（B-cell lymphoma-2/adenovirus E1B 19-kDa-interacting protein 3,BNIP3）通路、磷脂酰肌醇3激酶（phosphoinositide 3-kinase,PI3K）/蛋白激酶B（protein kinase B,AKT）/哺乳动物雷帕霉素靶蛋白（mammalian target of rapamycin,mTOR）等细胞通路诱导肿瘤细胞自噬水平的提高,从而产生治疗抵抗。体外试验中,自噬抑制剂的使用可以改善自噬引起的治疗抵抗。

关键词: 自噬, 原发性肝癌, 介入治疗

Abstract: Primary hepatic carcinoma is one of most common malignant tumors in China. Interventional therapy plays an important role in primary hepatic carcinoma, suitable for Ia-IIIb stage patients according to China liver cancer staging (CNLC). As a metabolic process unique to eukaryotic cells, autophagy is involved in metabolic diseases and malignant tumors, and plays an important role in the tumorigenesis of primary hepatic carcinoma, especially promoting the tolerance of tumor cells to interventional therapy, which makes the treatment ineffective. In this paper, we review the effects of common interventional treatments for primary hepatic carcinoma on autophagy in tumor cells. Ablation therapy, transvascular interventional therapy, and internal radiation therapy can promote levels of autophagy in tumor cells by cellular pathways such as hypoxia inducible factor-1α (HIF-1α)/B-cell lymphoma-2/adenovirus E1B 19-kDa-interacting protein 3 (BNIP3) pathway, phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR), resulting in treatment resistance. In vitro studies, the use of autophagy inhibitors has prevent therapeutic resistance from autophagy.

Key words: Autophagy, Primary hepatic carcinoma, Interventional therapy

余晨曦, 姚雪松. 自噬在肝癌介入治疗中的研究进展[J]. 肝癌电子杂志, 2023, 10(2): 33-36.

Yu Chenxi, Yao Xuesong. Research progress of autophagy in interventional therapy of primary hepatic carcinoma[J]. Electronic Journal of Liver Tumor, 2023, 10(2): 33-36.

参考文献

[1] ZHOU M, WANG H, ZENG X, et al.Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2019, 394(10204): 1145-1158.
[2] 中华人民共和国国家卫生健康委员会医政司. 原发性肝癌诊疗指南(2022年版)[J/CD]. 肝癌电子杂志, 2022, 9(1): 1-22.
[3] ALLEMANI C, MATSUDA T, DI CARLO V, et al.Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries[J]. Lancet, 2018, 391(10125): 1023-1075.
[4] SHAO B Z, CHAI N L, YAO Y, et al.Autophagy in gastrointestinal cancers[J]. Front Oncol, 2022, 12: 975758.
[5] DE DUVE C, WATTIAUX R.Functions of lysosomes[J]. Annu Rev Physiol, 1966, 28: 435-492.
[6] SAMIE M, LIM J, VERSCHUEREN E, et al.Selective autophagy of the adaptor TRIF regulates innate inflammatory signaling[J]. Nat Immunol, 2018, 19(3): 246-254.
[7] LAMARK T, JOHANSEN T.Mechanisms of Selective Autophagy[J]. Annu Rev Cell Dev Biol, 2021, 37: 143-169.
[8] KUO C J, HANSEN M, TROEMEL E.Autophagy and innate immunity: Insights from invertebrate model organisms[J]. Autophagy, 2018, 14(2): 233-242.
[9] ALLAIRE M, RAUTOU P E, CODOGNO P, et al.Autophagy in liver diseases: Time for translation?[J]. J Hepatol, 2019, 70(5): 985-998.
[10] HOU J, HAN Z, ZHAO N, et al.Autophagy and Tumour Metastasis[J]. Adv Exp Med Biol, 2020, 1207: 315-338.
[11] YANG J, PI C, WANG G.Inhibition of PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells[J]. Biomed Pharmacother, 2018, 103: 699-707.
[12] WANG Y, XIONG H, LIU D, et al.Autophagy inhibition specifically promotes epithelial-mesenchymal transition and invasion in RAS-mutated cancer cells[J]. Autophagy, 2019, 15(5): 886-899.
[13] YUE C, JIN H, ZHANG X, et al.Aucubin prevents steroid-induced osteoblast apoptosis by enhancing autophagy via AMPK activation[J]. J Cell Mol Med, 2021, 25(21): 10175-10184.
[14] JIN J, TU Q, GONG J, et al.Autophagy activity and expression pattern of autophagy-related markers in the podocytes of patients with lupus nephritis: association with pathological classification[J]. Ren Fail, 2019, 41(1): 294-302.
[15] GU Q, LI F, GE S, et al.CDC20 Knockdown and Acidic Microenvironment Collaboratively Promote Tumorigenesis through Inhibiting Autophagy and Apoptosis[J]. Mol Ther Oncolytics, 2020, 17: 94-106.
[16] CHEN Z, XIE H, HU M, et al.Recent progress in treatment of hepatocellular carcinoma[J]. Am J Cancer Res, 2020, 10(9): 2993-3036.
[17] VIGANO L, LAURENZI A, SOLBIATI L, et al.Open Liver Resection, Laparoscopic Liver Resection, and Percutaneous Thermal Ablation for Patients with Solitary Small Hepatocellular Carcinoma (≤30 mm): Review of the Literature and Proposal for a Therapeutic Strategy[J]. Dig Surg, 2018, 35(4): 359-371.
[18] XUAN D, WEN W, XU D, et al.Survival comparison between radiofrequency ablation and surgical resection for patients with small hepatocellular carcinoma: A systematic review and meta-analysis[J]. Medicine (Baltimore), 2021, 100(7): e24585.
[19] GUO Y, REN Y, DONG X, et al.An Overview of Hepatocellular Carcinoma After Insufficient Radiofrequency Ablation[J]. J Hepatocell Carcinoma, 2022, 9: 343-355.
[20] WANG F, XU C, LI G, et al.Incomplete radiofrequency ablation induced chemoresistance by up-regulating heat shock protein 70 in hepatocellular carcinoma[J]. Exp Cell Res, 2021, 409(2): 112910.
[21] ZHAO Z, WU J, LIU X, et al.Insufficient radiofrequency ablation promotes proliferation of residual hepatocellular carcinoma via autophagy[J]. Cancer Lett, 2018, 421: 73-81.
[22] XU W L, WANG S H, SUN W B, et al.Insufficient radiofrequency ablation-induced autophagy contributes to the rapid progression of residual hepatocellular carcinoma through the HIF-1alpha/BNIP3 signaling pathway[J]. BMB Rep, 2019, 52(4): 277-282.
[23] LI X, HE S, MA B.Autophagy and autophagy-related proteins in cancer[J]. Mol Cancer, 2020, 19(1): 12.
[24] LIN F, ZHU Y T, QIN Z H.Biomarkers of Autophagy[J]. Adv Exp Med Biol, 2021, 1208: 265-287.
[25] JIANG J, CHEN S, LI K, et al.Targeting autophagy enhances heat stress-induced apoptosis via the ATP-AMPK-mTOR axis for hepatocellular carcinoma[J]. Int J Hyperthermia, 2019, 36(1): 499-510.
[26] ZHOU J, SUN H C, WANG Z, et al.Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)[J]. Liver Cancer, 2018, 7(3): 235-260.
[27] LIU S, LAI J, LYU N, et al.Effects of Antiviral Therapy on HBV Reactivation and Survival in Hepatocellular Carcinoma Patients Undergoing Hepatic Artery Infusion Chemotherapy[J]. Front Oncol, 2021, 10: 582504.
[28] LIU M, SHI J, MOU T, et al.Systematic review of hepatic arterial infusion chemotherapy versus sorafenib in patients with hepatocellular carcinoma with portal vein tumor thrombosis[J]. J Gastroenterol Hepatol, 2020, 35(8): 1277-1287.
[29] CHEN S, ZHANG K, LIU W, et al.Hepatic arterial infusion of oxaliplatin plus raltitrexed in patients with intermediate and advanced stage hepatocellular carcinoma: A phase Ⅱ, single-arm, prospective study[J]. Eur J Cancer, 2020, 134: 90-98.
[30] 余晨曦, 滕皋军. 经导管动脉化疗栓塞术抵抗研究进展[J]. 介入放射学杂志, 2017, 26(12): 1063-1067.
[31] GAO L, SONG J R, ZHANG J W, et al.Chloroquine promotes the anticancer effect of TACE in a rabbit VX2 liver tumor model[J]. Int J Biol Sci, 2013, 9(4): 322-330.
[32] RANGEL M, KONG J, BHATT V, et al.Autophagy and tumorigenesis[J]. FEBS J, 2022, 289(22): 7177-7198.
[33] GADE T P F, TUCKER E, NAKAZAWA M S, et al. Ischemia Induces Quiescence and Autophagy Dependence in Hepatocellular Carcinoma[J]. Radiology, 2017, 283(3): 702-710.
[34] GOTO Y, HISAKA T, SAKAI H, et al.Salvage Surgery for Initially Unresectable Locally Advanced Hepatocellular Carcinoma Downstaged by Hepatic Arterial Infusion Chemotherapy[J]. Anticancer Res, 2020, 40(8): 4773-4777.
[35] QU X, SHENG J, SHEN L, et al.Autophagy inhibitor chloroquine increases sensitivity to cisplatin in QBC939 cholangiocarcinoma cells by mitochondrial ROS[J]. PLoS One, 2017, 12(3): e173712.
[36] JIN F, WANG Y, LI M, et al.MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy[J]. Cell Death Dis, 2017, 8(1): e2540.
[37] SHI Y, LIN G, ZHENG H, et al.Biomimetic nanoparticles blocking autophagy for enhanced chemotherapy and metastasis inhibition via reversing focal adhesion disassembly[J]. J Nanobiotechnology, 2021, 19(1): 447.
[38] SHENG J, QIN H, ZHANG K, et al.Targeting autophagy in chemotherapy-resistant of hepatocellular carcinoma[J]. Am J Cancer Res, 2018, 8(3): 354-365.
[39] HU H T, LUO J P, CAO G S, et al.Hepatocellular Carcinoma With Portal Vein Tumor Thrombus Treated With Transarterial Chemoembolization and Sorafenib vs. 125Iodine Implantation[J]. Front Oncol, 2021, 11: 806907.
[40] PENG W X, WAN Y Y, GONG A H, et al.Egr-1 regulates irradiation-induced autophagy through Atg4B to promote radioresistance in hepatocellular carcinoma cells[J]. Oncogenesis, 2017, 6(1): e292.
[41] WU J H, GUO J P, SHI J, et al.CMA down-regulates p53 expression through degradation of HMGB1 protein to inhibit irradiation-triggered apoptosis in hepatocellular carcinoma[J]. World J Gastroenterol, 2017, 23(13): 2308-2317.
[42] GAO L, ZHENG H, CAI Q, et al.Autophagy and Tumour Radiotherapy[J]. Adv Exp Med Biol, 2020, 1207: 375-387.